Vegan, Sugar-Free, And Now In Australia: Tilray's Edibles Aren't Your Average Medical Launch

Tilray Brands Inc. TLRY, through its healthcare-focused arm Tilray Medical, has rolled out its inaugural range of cannabis-infused medical edibles in Australia.

This development represents an important advancement in the firm's international growth efforts and enhances access to alternative, plant-derived treatment choices for patients.

Tilray Medical has launched its Good Supply Pastilles, a line of sugar-free, vegan-friendly edibles, now available to patients across Australia.

The new product range includes three variants: Good Supply Pastilles THC10 (Strawberry), THC10 CBD10 (Pineapple), and CBD20 (Raspberry).

Also Read: Retail Giant Costco Raises Dividend By 12%

“Our dedication to innovation and patient care drives us to continuously expand our offerings, ensuring that patients receive the best possible treatment options tailored to meet their needs and preferences,” said Chief Strategy Officer and Head of International, Denise Faltischek.

“The expansion of our medical cannabis portfolio with the introduction of Good Supply Pastilles in Australia is a significant milestone for Tilray Medical. We are committed to providing high-quality, accessible medical cannabis products in convenient formats to patients worldwide.”

Patients can purchase packs containing 60 pastilles through Tilray Direct or from licensed medical cannabis providers.

Tilray offers a wide range of THC and CBD products in over 20 countries and supports international clinical research on cannabis treatments.

Tilray Brands is a global lifestyle and consumer goods company with a focus on cannabis, beverages, wellness, and entertainment. Tilray’s products include cannabis, hemp foods, and craft beverages.

Price Action: TLRY shares traded lower by 6.58% at $0.44 at last check Thursday.

Read Next:

• Target Under Pressure From Discretionary Spend Slowdown, Mounting Inventory Risk, Goldman Sachs Downgrades Stock

Photo: Cannabis_Pic/Shutterstock